Wegovy is a self-injectable drug administered subcutaneously (under the skin) once a week with a single-dose, pre-filled pen injector
The Historic WEGOVY Pill Approval On December 22, 2025, the FDA made history
The main ingredient in Ozempic is called semaglutide, a man-made version of the human GLP-1 molecule, with some changes
Importantly, this wasnt just about numbers on a scale
This damage disrupts the normal flow of electrical signals between the brain and body, leading to a wide range of symptoms, including fatigue, mobility problems, vision issues, numbness, and cognitive changes